Apolipoprotein E Gene Polymorphism Effects on Lipid Metabolism and Risk of Cerebral Infarction in Northwest Han Chinese Population
- PMID: 37051559
- PMCID: PMC10083142
- DOI: 10.2147/PGPM.S404663
Apolipoprotein E Gene Polymorphism Effects on Lipid Metabolism and Risk of Cerebral Infarction in Northwest Han Chinese Population
Abstract
Background: The apolipoprotein E (ApoE) genetic variation may contribute to the development of Cerebral Infarction (CI). Serum lipid levels are known risk factors for CI, but the effect of the ApoE gene polymorphism on lipid metabolism remains unclear. This retrospective cohort study was designed to determine the role of ApoE genotypes in CI risk and the relationships between ApoE gene polymorphism and serum lipid levels among the population of northwest China.
Patients and methods: 517 CI patients and 517 non-CI controls were enrolled in the study. Polymerase chain reaction and hybridization were utilized to determine the ApoE gene polymorphisms.
Results: The ε3/ε4 genotype and ε4 allele frequency were significantly higher in CI patients than in controls. When stratified by age and sex, statistically significant differences in the distribution and frequency of the ε3/ε4 genotype and ε4 allele were found between patients and controls. Compared to ε2 carriers, ε4 carriers had significantly lower ApoE levels and higher low-density lipoprotein cholesterol (LDL-C), ApoB and ApoB/ApoA-I levels in both two groups. Additionally, control participants with ε4 carriers had significantly higher levels of lipoprotein and total cholesterol (TC) levels than ε2 carriers, while CI patients with ε4 carriers had a significantly lower level of ApoA-I. After adjusting for other established risk factors, drinking, hypertension, lipoprotein, triglycerides (TG) and ε4 allele were significant independent risk factors for CI, which was shown to be associated with a nearly two-fold CI risk.
Conclusion: This study demonstrated that ε4 allele is independent risk factors for CI among patients in Northwest China. ApoE polymorphism was associated with CI, which was partly mediated through blood lipids and may also be mediated through non-lipid pathways. These data might be of great clinical significance in individualized preventive and therapeutic strategies.
Keywords: Northwest China; apolipoprotein E; cerebral infarction; gene polymorphism.
© 2023 Wang et al.
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Apolipoprotein E Gene Polymorphism and Coronary Artery Disease Risk Among Patients in Northwest China.Pharmgenomics Pers Med. 2021 Dec 7;14:1591-1599. doi: 10.2147/PGPM.S338285. eCollection 2021. Pharmgenomics Pers Med. 2021. PMID: 34908864 Free PMC article.
-
Effect of Apolipoprotein E ε4 Allele on the Progression of Carotid Atherosclerosis Through Apolipoprotein Levels.Pharmgenomics Pers Med. 2022 Jun 21;15:653-661. doi: 10.2147/PGPM.S367471. eCollection 2022. Pharmgenomics Pers Med. 2022. PMID: 35761854 Free PMC article.
-
The SNPs rs429358 and rs7412 of APOE gene are association with cerebral infarction but not SNPs rs2306283 and rs4149056 of SLCO1B1 gene in southern Chinese Hakka population.Lipids Health Dis. 2020 Sep 5;19(1):202. doi: 10.1186/s12944-020-01379-4. Lipids Health Dis. 2020. PMID: 32891149 Free PMC article.
-
Association of apolipoprotein E genotypes with lipid levels and coronary risk.JAMA. 2007 Sep 19;298(11):1300-11. doi: 10.1001/jama.298.11.1300. JAMA. 2007. PMID: 17878422 Review.
-
Association of apolipoprotein E genotypes with epilepsy risk: A systematic review and meta-analysis.Epilepsy Behav. 2019 Sep;98(Pt A):27-35. doi: 10.1016/j.yebeh.2019.06.015. Epub 2019 Jul 9. Epilepsy Behav. 2019. PMID: 31299529
Cited by
-
Apolipoprotein E E3/E4 genotype is associated with an increased risk of premature coronary artery disease.BMC Cardiovasc Disord. 2024 Jul 10;24(1):353. doi: 10.1186/s12872-024-04021-8. BMC Cardiovasc Disord. 2024. PMID: 38987708 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Miscellaneous